Entry comments: Catalyst> (FDA) has granted Breakthrough Therapy Designation for PTI-428, the Company’s cystic fibrosis transmembrane conductance regulator (CFTR) amplifier. Bought the dip.
Exit comments: This stock was a faster mover, and I was very nervous being in it. I am just aiming for singles. Thanks for the lessons Tim :)